Close Menu

NEW YORK — Snibe Diagnostic said this week that it has received CE marking for its Maglumi SARS-CoV-2 Neutralizing Antibody Assay.

According to Snibe, the fully automated test can detect neutralizing antibodies against SARS-CoV-2 within 20 minutes when used with its Maglumi analyzers. It can be used to determine the immune status of COVID-19 patients and individuals who have been vaccinated against the virus, the Shenzhen, China said.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.